An interventional study of Group acceptance and commitment therapy (ACT) in Obsessive-Compulsive Disorder, sponsored by Universidade Federal do Paraná. Active, not recruiting at 1 site in Brazil. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-08-12.
Sponsored by Universidade Federal do Paraná · Not applicable, Interventional, and Treatment
Among 17 studies in Obsessive-Compulsive Disorder with a site in Brazil — 2 open to participants now, 3 under way, none of them phase 3. Obsessive-Compulsive Disorder · Brazil.
Among the 17 studies in Obsessive-Compulsive Disorder with a site in Brazil, this one is the 13th largest by planned enrollment, is one of 2 that started in 2022, is one of 8 with no phase, and was the 16th registered.
635 studies on the registry are indexed under Obsessive-Compulsive Disorder; 166 are open to participants now.
Browse Obsessive-Compulsive Disorder studies →2 of the 17 studies in Obsessive-Compulsive Disorder with a site in Brazil are open now. Recruiting first, the newest first:
Suellen Andrade · Sites in Brazil
University of Sao Paulo General Hospital · Sites in Brazil
A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →
Of the 120 Obsessive-Compulsive Disorder studies recruiting now, 31 (26%) set no upper age limit and 81 (68%) stop at 75 or younger; 28 take children under 18; 18 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
17 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 2 started in 2022.
This study's planned enrollment of 24 is below the median of 45 across 520 interventional studies indexed under Obsessive-Compulsive Disorder.
Median enrollment 40 across the 17 interventional studies. Of the 12 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 17 has an industry lead sponsor. The 8 most frequent:
Universidade Federal do Paraná is the lead sponsor of 15 studies on the registry; 4 are open to participants now.
Universidade Federal do Paraná has 1 study filed under Obsessive-Compulsive Disorder — fewer than ten, so there is no comparison to draw.
1 of the studies in Obsessive-Compulsive Disorder with a site in Brazil that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06658756University of Sao Paulo General HospitalImplementation of Internet-Based Psychotherapy for OCD in Primary Health Care in Two Cities in the State of São Paulo | 2027-01 |
Among the 17 studies in Obsessive-Compulsive Disorder with a site in Brazil, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to learn if Acceptance and Commitment Therapy (ACT) + Exposure and Response Prevention (ERP) in Group is effective to Obsessive Compulsive Disorder (OCD) in adults.
Researchers will compare intervention to control group to see if those who attend the group therapy have better results than control group.
Participants will go through a 16-week group therapy based on a protocol designed by Michael Twohig (Twohig et al, 2018).
The goal of this clinical trial is to learn if Acceptance and Commitment Therapy (ACT) + Exposure and Response Prevention (ERP) in Group is effective to Obsessive Compulsive Disorder (OCD) in adults. The main questions it aims to answer are:
Researchers will compare intervention (n=16) to control group (n=8) to see if those who attend the group therapy have better results than control group.
We will perform an unequal randomization in a 2:1 ratio, in blocks of 6, for allocation to each group. The assessor of the outcomes of interest will be blinded to the group to which the participant was assigned
Participants will go through a 16-week group therapy based on a protocol designed by Michael Twohig (Twohig et al, 2018).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
16 sessions of group psychotherapy based on ACT + exposure with response prevention (EPR)
Other: Group acceptance and commitment therapy (ACT)
Patients will follow their usual treatment, without adding ACT-based group psychotherapy
Group psychotherapy based on ACT + EPR
Also known as: Group Psychotherapy, Acceptance and Commitment Therapy, Psychotherapy
Yale-Brown Obsessive-Compulsive Scale (YBOCS)
Measure for assessing the presence and severity of obsessive-compulsive disorder (OCD) symptoms.
Time frame: 10 months (4-month intervention + 6-month follow-up)
Acceptance and Commitment Therapy Processes (CompACT)
Measure of psychological flexibility
Time frame: 10 months (4-month intervention + 6-month follow-up)
Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-SV)
Measures of the degree of enjoyment and satisfaction experienced by subjects in various areas of dally functioning
Time frame: 10 months (4-month intervention + 6-month follow-up)
Depression Anxiety and Stress Scale (DASS)
Set of self-report scales designed to measure the emotional states of depression, anxiety and stress.
Time frame: 10 months (4-month intervention + 6-month follow-up)
AAQ for Obsessions and Compulsions (AAQ-OC)
Self-report measure of experiential avoidance in response to unwanted intrusive thoughts.
Time frame: 10 months (4-month intervention + 6-month follow-up)
Affective Style Questionnaire (ASQ)
Brief instrument to measure individual differences in emotion regulation
Time frame: 10 months (4-month intervention + 6-month follow-up)
Clinical Global Impressions (CGI) Scale,
Quantify and track patient progress and treatment response over time.
Time frame: 10 months (4-month intervention + 6-month follow-up)
Plan to share: No
Started Aug 2022 (actual). Primary completion is estimated for Jun 2025, 34 months after the start.
Of 234 non-industry interventional studies with no phase under Obsessive-Compulsive Disorder, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 65. This study's planned 34 months is below that.
Counting every sponsor, half of 237 studies reached it within 43 months; a quarter within 22 and three quarters within 65.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Obsessive-Compulsive Disorder →
Universidade Federal do Paraná